Leo Pharma loses US region CEO – interim replacement found in current CFO
The dermatology firm Leo Pharma has a CEO hunt ahead, as the man currently in charge of its US operations has been poached by Cara Therapeutics. Until a replacement has been found, Leo Pharma's current CFO will take the reigns in the US.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
Leo Pharma is waving goodbye to its former CEO of its US operations, Christopher Posner. Posner has left the company to join the US-listed biotech business Cara Therapeutics, where he has sat on the board.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA fast tracks former Leo Pharma eczema candidate
For subscribers
